{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:10:52Z","timestamp":1790759452979,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.anpede.2026.504058","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:50:38Z","timestamp":1770295838000},"page":"504058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurodegeneration in Langerhans Cell Histiocytosis: beyond a Sequela"],"prefix":"10.1016","volume":"104","author":[{"given":"Vicente","family":"Santa-Mar\u00eda L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Guti\u00e9rrez-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodr\u00edguez-Vigil Iturrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Garc\u00eda-Obreg\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Lorite Reggiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Murciano Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Valero-Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Astigarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2026.504058_bib0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/neuonc\/noab107","article-title":"Histiocytosis and the nervous system: from diagnosis to targeted therapies","volume":"23","author":"Cohen Aubart","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.anpede.2026.504058_bib0010","doi-asserted-by":"crossref","first-page":"130.e1","DOI":"10.1016\/j.anpedi.2022.05.002","article-title":"Histiocitosis de c\u00e9lulas de Langerhans. Avances en la patogenia y pr\u00e1ctica cl\u00ednica","volume":"97","author":"Astigarraga","year":"2022","journal-title":"An Pediatr (Engl Ed)"},{"key":"10.1016\/j.anpede.2026.504058_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199407213310303","article-title":"Langerhans\u2019-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease","volume":"331","author":"Willman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpede.2026.504058_bib0020","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anpede.2026.504058_bib0025","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.anpede.2026.504058_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/11538540-000000000-00000","article-title":"Multisystem Langerhans cell histiocytosis in children: current treatment and future directions","volume":"13","author":"Minkov","year":"2011","journal-title":"Pediatric Drugs"},{"key":"10.1016\/j.anpede.2026.504058_bib0035","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2024025625","article-title":"Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads","volume":"145","author":"Thalhammer","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.anpede.2026.504058_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.75.1.17","article-title":"A multicentre retrospective survey of Langerhans\u2019 cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans\u2019 Cell Histiocytosis Study Group","volume":"75","author":"Donadieu","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpede.2026.504058_bib0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","article-title":"Risk factors for diabetes insipidus in Langerhans cell histiocytosis","volume":"46","author":"Grois","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12185-011-0965-x","article-title":"Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan","volume":"94","author":"Shioda","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.anpede.2026.504058_bib0055","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjh.15577","article-title":"Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study","volume":"183","author":"H\u00e9ritier","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpede.2026.504058_bib0060","first-page":"96","article-title":"Central diabetes insipidus as the inaugural manifestation of langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents","author":"Marchand","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anpede.2026.504058_bib0065","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cncr.35301","article-title":"Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures","volume":"130","author":"Bielamowicz","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/brain\/awh403","article-title":"Neuropathology of CNS disease in Langerhans cell histiocytosis","volume":"128","author":"Grois","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.anpede.2026.504058_bib0075","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.31348","article-title":"CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH-associated neurodegeneration and mass lesions","volume":"124","author":"McClain","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0080","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.immuni.2023.11.011","article-title":"Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders","volume":"56","author":"Wilk","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.anpede.2026.504058_bib0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood.2024026066","article-title":"BRAFV600E induces key features of LCH in iPSCs with cell type\u2013specific phenotypes and drug responses","volume":"145","author":"Abagnale","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.anpede.2026.504058_bib0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature23672","article-title":"A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease","volume":"549","author":"Mass","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.anpede.2026.504058_bib0095","article-title":"Mechanism of neurodegeneration mediated by clonal inflammatory microglia","author":"Vicario","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.anpede.2026.504058_bib0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpeds.2003.12.030","article-title":"Endocrine involvement in pediatric-onset langerhans\u2019 cell histiocytosis: a population-based study","volume":"144","author":"Donadieu","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpede.2026.504058_bib0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pbc.20021","article-title":"Permanent consequences in langerhans cell histiocytosis patients: a pilot study from the histiocyte society - late effects study Group","volume":"42","author":"Haupt","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pbc.20760","article-title":"Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis","volume":"48","author":"Mittheisz","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0115","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"H\u00e9ritier","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpede.2026.504058_bib0120","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.19483","article-title":"Neurodegeneration in patients with multisystem Langerhans cell histiocytosis treated with vemurafenib","author":"Trambusti","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpede.2026.504058_bib0125","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2022009067","article-title":"Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH","author":"Evseev","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.anpede.2026.504058_bib0130","article-title":"Diagnostic BRAFV600E blood predicts treatment failure and neurodegeneration and redefines paradigms of pediatric LCH","author":"Lin","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.anpede.2026.504058_bib0135","first-page":"65","article-title":"Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: current views and new vistas","author":"Yeh","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0140","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.2003.05.048","article-title":"Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study","volume":"21","author":"Nanduri","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpede.2026.504058_bib0145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/pbc.21656","article-title":"Neuropsychological sequelae in patients with neurodegenerative Langerhans cell histiocytosis","volume":"51","author":"Van\u2019t Hooft","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0150","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00415-014-7375-y","article-title":"The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis","volume":"261","author":"Le Guennec","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.anpede.2026.504058_bib0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pbc.22791","article-title":"Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study","volume":"56","author":"Laurencikas","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0160","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3174\/ajnr.A0509","article-title":"Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis","volume":"28","author":"Prosch","year":"2007","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.anpede.2026.504058_bib0165","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s11604-013-0254-0","article-title":"Neuroimaging of Langerhans cell histiocytosis: A radiological review","volume":"31","author":"Chaudhary","year":"2013","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.anpede.2026.504058_bib0170","first-page":"10","article-title":"Early diagnosis and monitoring of neurodegenerative langerhans cell histiocytosis","author":"Sieni","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.anpede.2026.504058_bib0175","first-page":"15","article-title":"A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study","author":"Trambusti","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.anpede.2026.504058_bib0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/bjh.17781","article-title":"Response to mitogen-activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study","volume":"196","author":"Henter","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpede.2026.504058_bib0185","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/bjh.19376","article-title":"Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis","volume":"204","author":"Parekh","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpede.2026.504058_bib0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/pbc.22326","article-title":"Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine\/cytosine arabinoside","volume":"54","author":"Allen","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2026.504058_bib0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12185-014-1717-5","article-title":"Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease","volume":"101","author":"Imashuku","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.anpede.2026.504058_bib0200","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.19380","article-title":"Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis","author":"Karri","year":"2024","journal-title":"Br J Haematol"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287926000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287926000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:33:48Z","timestamp":1772123628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287926000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2341287926000098"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2026.504058","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurodegeneration in Langerhans Cell Histiocytosis: beyond a Sequela","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2026.504058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2025.504058","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"504058"}}